A research project to find out if a ‘polypill’ can help reduce the chance that people who have had a stroke will have a heart attack or another stroke.
Local stroke survivors have joined in a new stroke research program at the Stroke Association’s Life After Stroke Centre in Bromsgrove on Monday 05 September. STARR (stroke, technology and risk reduction) is a new research program, which will help stroke survivors manage their risk factors for recurrent stroke: a stroke that happens after someone has their first stroke.
This research will investigate the use of orthitics (for example, braces and splints) early on in a stroke survivor’s rehabilitation. The results will inform a larger study into early orthotic use after stroke.
A system of supported decision making and self-management for the prevention of secondary stroke.
This research can improve a camera-based computer programme so it can be used by health care professionals and stroke survivors to help in physical rehabilitation.
Understanding the difficulty in controlling emotions after stroke
No two strokes are alike - the damage from each stroke leaves its own unique signature on a person's brain and behaviour. The current project will investigate how different types of stroke affect a person's long term recovery or deterioration
Cerebral venous thrombosis (CVT) is an unusual form of stroke. It is little researched largely because it accounts for less than 1% of all strokes. The study will provide a much better understanding for the reasons underlying CVT, which is an unusual but very important cause of stroke in young (mainly female) adults.
People who have survived a previous stroke or transient ischaemic attack (TIA) are at particularly high risk of subsequent, ‘recurrent’ stroke with 30% having another stroke in the following five years. High blood pressure is the most important reversible risk factor for having a recurrent stroke.
This study will investigate whether reducing blood pressure can stop bleeding in the brain after thrombolysis (a clot-busting treatment for stroke) and improve patient's outcomes.